More than six years after he finished serving eight months of a two-year prison sentence, Dr. Darryl Jordan Gebien wants to talk about his experience, in hopes of helping other people with addictions.
I sometimes joke that my children’s university tuition has been paid by midlife relationship instability because I see so many people in their forties and fifties who test HPV positive.
At the heart of Novo Nordisk’s acquisition of Montreal-based Inversago Pharma is an oral agonist designed to block the receptor protein CB1, which plays an important role in metabolism and appetite regulation.
